resveratrol has been researched along with Corneal Angiogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, Y; Li, M; Wu, Z; Yu, X; Zhu, L | 1 |
| Cankaya, C; Doganay, S; Firat, PG; Kirimlioglu, H | 1 |
2 other study(ies) available for resveratrol and Corneal Angiogenesis
| Article | Year |
|---|---|
Ocular lamellar crystalline gels for sustained release and enhanced permeation of resveratrol against corneal neovascularization.
Topics: Administration, Ophthalmic; Animals; Burns, Chemical; Cell Line; Computer Simulation; Corneal Injuries; Corneal Neovascularization; Crystallization; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Enzyme Inhibitors; Epithelial Cells; Epithelium, Corneal; Ethanol; Eye Burns; Gels; Glycerides; Humans; In Vitro Techniques; Liquid Crystals; Molecular Docking Simulation; Ocular Absorption; Powder Diffraction; Rats; Resveratrol; Scattering, Small Angle; Spectroscopy, Fourier Transform Infrared; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Water; Wound Healing | 2021 |
Evaluation of the effects of resveratrol and bevacizumab on experimental corneal alkali burn.
Topics: Alkalies; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Bevacizumab; Burns, Chemical; Corneal Neovascularization; Disease Models, Animal; Eye Burns; Male; Rabbits; Resveratrol; Stilbenes | 2013 |